PALISADE CAPITAL MANAGEMENT, LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,740,000
-36.5%
2,000,000
-33.3%
0.06%
-44.0%
Q4 2018$2,740,000
-12.5%
3,000,0000.0%0.10%
+14.9%
Q3 2018$3,133,000
-19.8%
3,000,000
-20.3%
0.09%
-23.0%
Q2 2018$3,905,000
-24.4%
3,766,000
-24.7%
0.11%
-35.4%
Q1 2018$5,166,000
+19.4%
5,000,0000.0%0.18%
+19.9%
Q4 2017$4,325,000
-11.1%
5,000,0000.0%0.15%
-15.6%
Q3 2017$4,863,000
+1.0%
5,000,0000.0%0.17%
-3.9%
Q2 2017$4,815,0005,000,0000.18%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 1,500,000$1,492,0002.87%
Telemetry Investments, L.L.C. 8,000,000$7,780,0002.78%
Context Capital Management, LLC 3,500,000$3,405,0002.28%
Kamunting Street Capital Management, L.P. 2,500,000$2,431,0001.54%
BASSO CAPITAL MANAGEMENT, L.P. 12,205,000$11,824,0001.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 17,500,000$17,269,0001.34%
CAMDEN ASSET MANAGEMENT L P /CA 32,375,000$31,485,0001.04%
Jabre Capital Partners S.A. 5,500,000$5,328,0001.04%
City Financial Investment Co Ltd 12,500,000$12,168,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,250,000$15,747,0000.71%
View complete list of AMAG PHARMACEUTICALS INC shareholders